|
Healthcare Reform
Key Obamacare Actions for U.S. Rx Manufacturers in 2015
At first glance Obamacare developments for the American Rx industry in 2015 appear fairly benign. However, digging deeper suggests that each, in its own way, could cause various actions with potential for substantial uncertainty for the U.S. pharmaceutical industry next year. If your response to this profound observation was, “Really, what’s new?” then read on ...Read more
Drug Pricing
Express to Center Stage
William Looney profiles Express Scripts’ Chief Medical Officer, Dr. Steve Miller, whose rise to prominence as an articulate critic of drug industry prices symbolizes the growing clout of America’s largest pharmacy benefit manager (PBM). Miller may rank high on today’s list of “pharma’s most feared”—until you pause to consider how closely his background resembles that of so many of his c-suite drug industry peers ...Read more
Best Practices for a Successful Global Access Program
Monday, January 12, 2015, 11:00 AM Eastern Standard Time
 Click here
to Register Free.
Pharma Services
AmerisourceBergen: A Burgeoning Giant Steps Out
While globalization as a business strategy has been embraced by Big Pharma for the past decade, its network of providers, payers, distributors and service vendors has been slow to follow suit. A subtle and unmistakable shift is now underway among these low-profile drivers of the industry’s supply chain, however, and leading this trend is the $100 billion sourcing and distribution behemoth AmerisourceBergen (ABC). Pharm Exec speaks to ABC’s Peyton Howell ...Read more
Global
Read the Pharm Exec ‘Toward 2015’ Special
In this special digital issue: Europe and Transparency in 2015; Cloud Technology: a Five-Year Outlook; Brazil’s Revised Growth Forecast; Warehousing and the Future of the HCV Treatment Market; and more
...Read more
|
